Kraig Biocraft Laboratories Announces That the First Stage of Its Pilot Production Program Has Resulted in Monster Silk(TM) Coc
March 04 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company" or
"Kraig"), the leading developer of advanced spider silk based
fibers, announced today that the silkworm hatchlings from the first
stage of its Monster Silk™ pilot production program ("program")
have now spun cocoons. The cocoons are made of Monster Silk™, the
Company's recombinant spider silk.
The program is running in three stages, with stage 1 being the
first of the production stages to produce Monster Silk™ cocoons.
Stage 2 of the program is now entering a very advanced
state. All three stages are ahead of schedule and are hitting
or exceeding their milestones.
"Our focus on innovation and scientific excellence is
transitioning well from the laboratory to production, and this
ambitious pilot production program is designed to test our systems
and to become the basis for large commercial scale production,"
said Company founder and CEO, Kim K. Thompson.
"The pilot production program goals included confirming Monster
Silk's™ production scalability; to get these results so smoothly is
a tremendous boost the Company's expansion plans."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024